Skip to main content
. 2019 May 30;21(5):e13551. doi: 10.2196/13551

Table 2.

Patients’ acceptability of the Electronic Inhalation Monitoring Device (EIMD) program. Values in italics indicate the highest percentage(s) per statement.

Statement Disagree (score 1-2), n (%) Neutral (score 3), n (%) Agree (score 4-5), n (%)
The EIMD programme does provide useful insights in my medication usea 11 (44) 3 (12) 11 (44)
The EIMD programme is useful to me 6 (24) 8 (32) 11 (44)
The EIMD programme is time-consuming 19 (76) 2 (8) 4 (16)
The motivational messages in the EIMD app feel positive for me 11 (44) 10 (40) 4 (16)
The reminders of the EIMD programme help me to take my medication in time 10 (40) 6 (24) 9 (36)
The EIMD programme contributes to dealing with my illnessa 10 (40) 5 (20) 10 (40)
The EIMD programme contributes to the interaction with my pharmacist 10 (40) 8 (32) 7 (28)
The EIMD programme helps establishing a habit to use my medication 11 (44) 9 (36) 5 (20)
The EIMD programme gives me confidence to help manage my disease 10 (40) 9 (36) 6 (24)
The pharmacist’s monitoring of my medication use with this programme helps me to use my medication bettera 13 (52) 6 (24) 6 (24)
When someone can monitor my medication intake, I take my medication as usuala 4 (16) 3 (12) 18 (72)
I see added value of the EIMD programme to manage my medication intakea 11 (44) 5 (20) 9 (36)
I would recommend the EIMD programme to other patients 7 (28) 12 (48) 6 (24)
The pharmacist can play an important role in counselling 2 (8) 3 (12) 20 (80)

aItem was phrased as a negative statement.